Gongwin Biopharm Holdings Co., Ltd. (TPEX: 6617)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
109.00
-4.00 (-3.54%)
Oct 11, 2024, 1:30 PM CST

Gongwin Biopharm Holdings Market Cap

Gongwin Biopharm Holdings has a market cap or net worth of 13.90 billion as of October 11, 2024. Its market cap has decreased by -34.25% in one year.

Market Cap
13.90B
Enterprise Value
11.25B
Revenue
31.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
109.00

Market Cap Chart

Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 13.90B, an increase of 56.75%. That is a compound annual growth rate of 6.03%.

History

DateMarket Cap% Change
Oct 11, 202413.90B-33.54%
Dec 29, 202320.91B-42.13%
Dec 30, 202236.13B16.16%
Dec 30, 202131.10B17.15%
Dec 31, 202026.55B222.07%
Dec 31, 20198.24B20.08%
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Feb 8, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition